263 related articles for article (PubMed ID: 11031211)
1. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211
[TBL] [Abstract][Full Text] [Related]
2. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.
Leitinger N; Tyner TR; Oslund L; Rizza C; Subbanagounder G; Lee H; Shih PT; Mackman N; Tigyi G; Territo MC; Berliner JA; Vora DK
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12010-5. PubMed ID: 10518567
[TBL] [Abstract][Full Text] [Related]
3. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.
Subbanagounder G; Deng Y; Borromeo C; Dooley AN; Berliner JA; Salomon RG
Vascul Pharmacol; 2002 Apr; 38(4):201-9. PubMed ID: 12449016
[TBL] [Abstract][Full Text] [Related]
4. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
[TBL] [Abstract][Full Text] [Related]
5. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.
Watson AD; Leitinger N; Navab M; Faull KF; Hörkkö S; Witztum JL; Palinski W; Schwenke D; Salomon RG; Sha W; Subbanagounder G; Fogelman AM; Berliner JA
J Biol Chem; 1997 May; 272(21):13597-607. PubMed ID: 9153208
[TBL] [Abstract][Full Text] [Related]
6. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.
Watson AD; Subbanagounder G; Welsbie DS; Faull KF; Navab M; Jung ME; Fogelman AM; Berliner JA
J Biol Chem; 1999 Aug; 274(35):24787-98. PubMed ID: 10455151
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of oxidized phospholipids in cultured macrophages.
Stemmer U; Dunai ZA; Koller D; Pürstinger G; Zenzmaier E; Deigner HP; Aflaki E; Kratky D; Hermetter A
Lipids Health Dis; 2012 Sep; 11():110. PubMed ID: 22958747
[TBL] [Abstract][Full Text] [Related]
8. Uptake and protein targeting of fluorescent oxidized phospholipids in cultured RAW 264.7 macrophages.
Stemmer U; Ramprecht C; Zenzmaier E; Stojčić B; Rechberger G; Kollroser M; Hermetter A
Biochim Biophys Acta; 2012 Apr; 1821(4):706-18. PubMed ID: 22333180
[TBL] [Abstract][Full Text] [Related]
9. The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells.
Fruhwirth GO; Moumtzi A; Loidl A; Ingolic E; Hermetter A
Biochim Biophys Acta; 2006 Sep; 1761(9):1060-9. PubMed ID: 16904371
[TBL] [Abstract][Full Text] [Related]
10. Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells.
Moumtzi A; Trenker M; Flicker K; Zenzmaier E; Saf R; Hermetter A
J Lipid Res; 2007 Mar; 48(3):565-82. PubMed ID: 17135656
[TBL] [Abstract][Full Text] [Related]
11. Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC.
Birukova AA; Starosta V; Tian X; Higginbotham K; Koroniak L; Berliner JA; Birukov KG
Transl Res; 2013 Jun; 161(6):495-504. PubMed ID: 23305708
[TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells.
Loidl A; Sevcsik E; Riesenhuber G; Deigner HP; Hermetter A
J Biol Chem; 2003 Aug; 278(35):32921-8. PubMed ID: 12816958
[TBL] [Abstract][Full Text] [Related]
13. Molecular-Scale Biophysical Modulation of an Endothelial Membrane by Oxidized Phospholipids.
Ayee MAA; LeMaster E; Shentu TP; Singh DK; Barbera N; Soni D; Tiruppathi C; Subbaiah PV; Berdyshev E; Bronova I; Cho M; Akpa BS; Levitan I
Biophys J; 2017 Jan; 112(2):325-338. PubMed ID: 28122218
[TBL] [Abstract][Full Text] [Related]
14. The Levels of Oxidized Phospholipids in High-Density Lipoprotein During the Course of Sepsis and Their Prognostic Value.
Li Z; Luo Z; Shi X; Pang B; Ma Y; Jin J
Front Immunol; 2022; 13():893929. PubMed ID: 35592322
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of oxidized phosphatidylcholines in cultured human melanoma cells.
Ramprecht C; Jaritz H; Streith I; Zenzmaier E; Köfeler H; Hofmann-Wellenhof R; Schaider H; Hermetter A
Chem Phys Lipids; 2015 Jul; 189():39-47. PubMed ID: 26028612
[TBL] [Abstract][Full Text] [Related]
16. Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: role of ceramide synthases.
Halasiddappa LM; Koefeler H; Futerman AH; Hermetter A
PLoS One; 2013; 8(7):e70002. PubMed ID: 23936132
[TBL] [Abstract][Full Text] [Related]
17. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells.
Lee H; Shi W; Tontonoz P; Wang S; Subbanagounder G; Hedrick CC; Hama S; Borromeo C; Evans RM; Berliner JA; Nagy L
Circ Res; 2000 Sep; 87(6):516-21. PubMed ID: 10988245
[TBL] [Abstract][Full Text] [Related]
18. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration.
Cherepanova OA; Pidkovka NA; Sarmento OF; Yoshida T; Gan Q; Adiguzel E; Bendeck MP; Berliner J; Leitinger N; Owens GK
Circ Res; 2009 Mar; 104(5):609-18. PubMed ID: 19168440
[TBL] [Abstract][Full Text] [Related]
19. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
[TBL] [Abstract][Full Text] [Related]
20. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
